Cargando…
Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation
This study was designed to determine the efficacy of a new oral anticoagulant (NOAC) therapy for the prevention of endothelial dysfunction and atherosclerosis progression in patients with atrial fibrillation (AF). Sixty-five AF patients with a CHA2DS2-VASc score ≥2 without previous history of cardio...
Autores principales: | Jang, Gyeong-Won, Lee, Jung Myung, Choi, Seung Woo, Kim, Joan, Lee, Young Shin, Kim, Hyung Oh, Chung, Hyemoon, Woo, Jong Shin, Kim, Jin Bae, Kim, Woo-Shik, Kim, Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509820/ https://www.ncbi.nlm.nih.gov/pubmed/34640348 http://dx.doi.org/10.3390/jcm10194332 |
Ejemplares similares
-
Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial
por: Kim, Jin-Bae, et al.
Publicado: (2016) -
Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease
por: Choi, Seung Woo, et al.
Publicado: (2022) -
Effects of Acupuncture on Cardiac Remodeling in Patients with Persistent Atrial Fibrillation: Results of a Randomized, Placebo-Controlled, Patient- and Assessor-Blinded Pilot Trial and Its Implications for Future Research
por: Lee, Jung Myung, et al.
Publicado: (2021) -
Reduced Coronary Flow Reserve Is Associated with Impaired Ventricular-vascular Interaction in Patients with Obstructive Sleep Apnea
por: Chung, Hyemoon, et al.
Publicado: (2020) -
Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea
por: Kim, Joan, et al.
Publicado: (2022)